01 1Aurisco Pharmaceutical
01 1TENOFOVIR DISOPROXIL FUMARATE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-03-31
Pay. Date : 2016-07-25
DMF Number : 30730
Submission : 2016-07-25
Status : Active
Type : II
20
Aurisco Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their notable products is TENOFOVIR DISOPROXIL FUMARATE, with a corresponding US DMF Number 30730.
Remarkably, this DMF maintains an Active status since its submission on July 25, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 31, 2017, and payment made on July 25, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
